These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 20948953)
1. The global challenge of antimicrobial resistance: insights from economic analysis. Eggleston K; Zhang R; Zeckhauser RJ Int J Environ Res Public Health; 2010 Aug; 7(8):3141-9. PubMed ID: 20948953 [TBL] [Abstract][Full Text] [Related]
2. Antimicrobial Resistance: Threat, consequences and options. Bhatia R Natl Med J India; 2018; 31(3):133-135. PubMed ID: 31044757 [No Abstract] [Full Text] [Related]
3. The Role of Antibiotic Stewardship and Telemedicine in the Management of Multidrug-Resistant Infections. File TM; Jump RLP; Goff DA Infect Dis Clin North Am; 2020 Dec; 34(4):903-920. PubMed ID: 33131574 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic resistance as a major public health concern: epidemiology and economic impact. Ciorba V; Odone A; Veronesi L; Pasquarella C; Signorelli C Ann Ig; 2015; 27(3):562-79. PubMed ID: 26152543 [TBL] [Abstract][Full Text] [Related]
5. Global Antimicrobial Stewardship with a Focus on Low- and Middle-Income Countries. Pierce J; Apisarnthanarak A; Schellack N; Cornistein W; Maani AA; Adnan S; Stevens MP Int J Infect Dis; 2020 Jul; 96():621-629. PubMed ID: 32505875 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials. Thabit AK; Crandon JL; Nicolau DP Expert Opin Pharmacother; 2015 Feb; 16(2):159-77. PubMed ID: 25496207 [TBL] [Abstract][Full Text] [Related]
7. Clinical impact and relevance of antibiotic resistance. French GL Adv Drug Deliv Rev; 2005 Jul; 57(10):1514-27. PubMed ID: 15978698 [TBL] [Abstract][Full Text] [Related]
8. Economics of antibiotic resistance. Sipahi OR Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118 [TBL] [Abstract][Full Text] [Related]
9. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do? Penchovsky R; Traykovska M Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754 [TBL] [Abstract][Full Text] [Related]
10. Burden of antimicrobial resistance in an era of decreasing susceptibility. Tillotson GS; Zinner SH Expert Rev Anti Infect Ther; 2017 Jul; 15(7):663-676. PubMed ID: 28580804 [TBL] [Abstract][Full Text] [Related]
11. A call to arms: the imperative for antimicrobial stewardship. Bartlett JG Clin Infect Dis; 2011 Aug; 53 Suppl 1():S4-7. PubMed ID: 21795727 [TBL] [Abstract][Full Text] [Related]
19. Surveillance and management of multidrug-resistant microorganisms. Orsi GB; Falcone M; Venditti M Expert Rev Anti Infect Ther; 2011 Aug; 9(8):653-79. PubMed ID: 21819331 [TBL] [Abstract][Full Text] [Related]
20. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents. Payne D; Tomasz A Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496 [No Abstract] [Full Text] [Related] [Next] [New Search]